University spinouts boom as startups pull in billions SME Academics are increasingly going on to start their own start-ups, with a surge in spinouts, patents and investment pointing to the growing commercial impact of Britain’s research base. New figures seen by City AM show the number of UCL academics seeking to commercialise their research has jumped by more than 25 per cent since the [...]
Lack of trust in AI tempers Starmer’s tech push Tech Britain’s AI sector has entered the year with continued momentum, with its leading heavyweights raising over £20bn in private capital over the past year. According to Startup Coalition’s latest AI index, British AI firms command a combined valuation north of £45bn. Business services accounted for roughly 400 AI startups, attracting £8.3bn, while financial services and [...]
UK firms eye AI spending in 2026, but skills gap threatens rollout A third of British businesses plan to invest in AI in 2026, yet new data suggests the bigger challenge may be readying staff for the technology, rather than rolling it out at speed. Research from Lloyds Bank’s recent business barometer revealed that 33 per cent of firms intend to invest in AI tools next year, [...]
Mark Carney’s Canadian win presents an opportunity for UK businesses April 29, 2025 Mark Carney’s victory in Canada presents a unique opportunity for UK businesses willing to seize it, writes Michael Martins.
Rightmove bidding battle shows that UK plc isn’t ‘for sale at any price’ September 23, 2024 A “lack of engagement” from Rightmove may have come as a surprise to Rupert Murdoch’s property group REA after it tabled not one but two takeover offers for the British company this month. On Monday, REA’s boss Owen Wilson said he was “genuinely disappointed” that Rightmove was unmoved by the interest, as the Australian firm [...]
Eco Animal Health beats expectations thanks to Americas growth July 15, 2024 Animal vaccine firm Eco Animal Health beat earnings expectations despite continuing volatility in currency, thanks largely to its "robust" demand for its flagship vaccine and consistent market leading position.